Efficacy and Safety of the Farnesyl-transferase Inhibitor (Tipifarnib) in Mantle Cell Lymphoma
Clinical trial NCT00847223 · TERMINATED
Trial details
- NCT number
- NCT00847223
- Sponsor
- Lymphoma Study Association
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2009-03-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.